Current Pharmaceutical Management of Diabetes
Advertisement
repaglinide (Prandin) (Continued)
Start with low dose (0.5-2.0 mg/meal); increase weekly PRN (Maximum recommended dose is 4 mg/meal, 16 mg/day)
Approved for monotherapy or with metformin
May cause hypoglycemia
Weight gain possible
Previous slide
Next slide
Back to first slide
View graphic version
Advertisements
Google Ads
[
Top
]
Webpage new at the
Diabetes
Monitor
12June2000